Safety, Tolerability, and Pharmacokinetics of ARC‐520 Injection, an RNA Interference‐Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers
Thomas Schluep; Jason Lickliter; James Hamilton; David L. Lewis; Ching‐Lung Lai; Johnson YN Lau; Stephen A. Locarnini; Robert G. Gish; Bruce D. Given
Author Information: Arrowhead Pharmaceuticals, Inc.
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.